Loss of membranous VEGFR1 expression is associated with an adverse phenotype and shortened survival in breast cancer

Angiogenesis is a key process in tumor growth and progression, which is controlled by vascular endothelial growth factors (VEGFs) and their receptors (VEGFRs). In order to better understand the prevalence and prognostic value of VEGFR1 expression in breast cancer, a tissue microarray containing >...

Descripción completa

Detalles Bibliográficos
Autores principales: Lebok, Patrick, Huber, Julia, Burandt, Eike-Christian, Lebeau, Annette, Marx, Andreas Holger, Terracciano, Luigi, Heilenkötter, Uwe, Jänicke, Fritz, Müller, Volkmar, Paluchowski, Peter, Geist, Stefan, Wilke, Christian, Simon, Ronald, Sauter, Guido, Quaas, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940099/
https://www.ncbi.nlm.nih.gov/pubmed/27357606
http://dx.doi.org/10.3892/mmr.2016.5430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940099/
https://www.ncbi.nlm.nih.gov/pubmed/27357606
http://dx.doi.org/10.3892/mmr.2016.5430

Ejemplares similares